25 January 2016
: Case report
Comparison of Superb Micro-Vascular Ultrasound Imaging (SMI) and Contrast-Enhanced Ultrasound (CEUS) for Detection of Endoleaks After Endovascular Aneurysm Repair (EVAR)
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Educational Purpose (only if useful for a systematic review or synthesis)
Marcin GabrielABDE, Jolanta TomczakABEF, Magdalena Snoch-ZiółkiewiczAE, Łukasz DzieciuchowiczA, Ewa StraussA, Grzegorz OszkinisADOI: 10.12659/AJCR.895415
Am J Case Rep 2016; 17:43-46
Abstract
BACKGROUND: High-resolution contrast-enhanced ultrasound is one of methods used in the detection and characterization of endoleaks, which is a frequent complication after EVAR. A new technology provided by Toshiba’s AplioTM 500 ultrasound system, called Superb Micro-Vascular Imaging (SMI), is dedicated specifically to imaging very low flow states and appears to be a promising new method for detection of endoleaks.
CASE REPORT: After endovascular treatment, a 68-year-old patient who had stent-graft implantation underwent clinical examinations, including contrast-enhanced ultrasound (CEUS), superb micro-vascular imaging (SMI), and computed tomographic angiography (CTA), revealing additional information about abnormal blood flow localized in the periphery of the sack of the left common iliac artery aneurysm. By using CEUS and SMI, the endoleak was clearly visible.
CONCLUSIONS: This case report illustrates the potential clinical value of this advanced Doppler technology (SMI) and how it could influence clinical management.
Keywords: Endoleak - ultrasonography, Contrast Media, endovascular procedures, Iliac Aneurysm - ultrasonography, Phospholipids, Sulfur Hexafluoride, Ultrasonography, Doppler, Color - methods
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946488
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946876
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946560
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946727
Most Viewed Current Articles
21 Jun 2024 : Case report
96,182
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,159
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
31,026
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,365
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030